Future Prospects in the Wake of COVID-19 for Indian MSMEs Pharmaceutical Sector

Please use this identifier to cite or link to this item: http://library.ediindia.ac.in:8181/xmlui//handle/123456789/13224

Full metadata record

DC Field	Value	Language
dc.contributor.author	Khetarpal, Ruchika	-
dc.date.accessioned	2022-03-12T09:35:42Z	-
dc.date.available	2022-03-12T09:35:42Z	-
dc.date.issued	2022-02-24	-
dc.identifier.uri	http://library.ediindia.ac.in:8181/xmlui//handle/123456789/13224	-
dc.description	International Conference on ‘Empowering Women Entrepreneurs from the Grassroots to Global’ - February 24-25, 2022	en_US
dc.description.abstract	The paper analyses the current scenario of the Pharmaceutical Sector in Indian MSMEs after Covid-19. The sector has a presence at a global level having 20-22% of global export volume and it is already a world leader in cost-cutting. The industry has the ability to contribute towards economic growth by leveraging business in and around the boundaries of the country. To know the competitiveness of the industry in the present scenario, the paper analyses the previous pattern based on secondary data from reliable sources. The paper also aims to predict the future prospects of the industry having a large base of manufacturing and export.	en_US
dc.language.iso	en	en_US
dc.publisher	Entrepreneurship Development Institute of India	en_US
dc.subject	MSMEs	en_US
dc.subject	Economic growth	en_US
dc.subject	Pharmaceutical sector	en_US
dc.subject	Covid-19	en_US
dc.title	Future Prospects in the Wake of COVID-19 for Indian MSMEs Pharmaceutical Sector	en_US
dc.type	Article	en_US
Appears in Collections:	Opportunities and Reorientation of Business during the Pandemic Time

Files in This Item:

File	Description	Size	Format
PC22.pdf Restricted Access		389.23 kB	Adobe PDF	View/Open Request a copy

DSpace JSPUI